| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/11/1995 | WO1995012612A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase |
| 05/11/1995 | WO1995012611A1 Endothelin receptor antagonists |
| 05/11/1995 | WO1995012610A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 05/11/1995 | WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications |
| 05/11/1995 | CA2173875A1 Endothelin receptor antagonists |
| 05/11/1995 | CA2173844A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 05/11/1995 | CA2173107A1 Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzyme |
| 05/11/1995 | CA2170766A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase |
| 05/10/1995 | EP0652229A2 Oligopeptides with fungicidal activity |
| 05/10/1995 | EP0652228A1 Urethanes and ureas that induce cytokine production |
| 05/10/1995 | EP0651763A1 Oligopeptide collagen derivatives and their use in secondary cataract prevention |
| 05/10/1995 | EP0651761A1 Method for modification of recombinant polypeptides |
| 05/10/1995 | EP0400051B1 Polypeptide compounds having growth hormone releasing activity |
| 05/09/1995 | US5414132 Peptide intermediates |
| 05/09/1995 | US5414017 Cardiovascular agents |
| 05/09/1995 | US5414013 Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same |
| 05/09/1995 | CA1335493C Process for the preparation of tripeptides |
| 05/04/1995 | WO1995011917A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 05/04/1995 | WO1995011910A1 2'-amido and 2'-peptido modified oligonucleotides |
| 05/04/1995 | WO1995003327A3 Peptides for neutralizing the toxicity of lipid a |
| 05/04/1995 | DE4337270A1 Substituted heterocyclic carboxamidoesters, their preparation and their use as medicaments |
| 05/04/1995 | CA2174339A1 2'-amido and 2'-peptido modified oligonucleotides |
| 05/04/1995 | CA2173590A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 05/03/1995 | EP0650961A1 Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments |
| 05/03/1995 | EP0650960A1 Substituted heterocyclic carboxylic acid amide esters, their preparation and their us as medicaments |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 05/03/1995 | CA2134866A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 05/03/1995 | CA2134865A1 Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals |
| 05/02/1995 | US5412125 Dipeptidic amides derived from glycyl-serine as surfactants or hydrating agents and cosmetic, pharmaceutical or alimentary compositions containing the same |
| 05/02/1995 | US5411964 Phenylalanine-glycine compounds having anti-tumor activity, process for preparation thereof, and pharmaceutical composition containing said compounds |
| 05/02/1995 | US5411942 Peptide derivative, pharmaceutical preparation containing it and method for treatment of glaucoma |
| 04/29/1995 | CA2134418A1 Linear adhesion inhibitors |
| 04/27/1995 | WO1995011045A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | CA2173972A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/26/1995 | EP0649443A1 Oxazolone derived materials |
| 04/26/1995 | EP0649434A1 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 04/26/1995 | EP0649432A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 04/26/1995 | EP0649426A1 Inhibitors of retroviral proteases |
| 04/26/1995 | EP0649414A1 Opioid diarylmethylpiperazines and piperidines |
| 04/26/1995 | EP0649312A1 Anthracycline conjugates, their preparation and their use as antitumor agents |
| 04/26/1995 | CN1101908A Angiotensin II antagonists |
| 04/25/1995 | US5410024 Cellular antigrowth agent |
| 04/25/1995 | US5409927 Morpholin- and thiomorpholin-4-ylamides |
| 04/20/1995 | WO1995010628A2 Signal transduction via cd28 |
| 04/20/1995 | WO1995010532A1 Compounds useful in anti-allergy treatment |
| 04/20/1995 | WO1995010531A1 Oligopeptides derived from c-reactive protein fragments |
| 04/20/1995 | WO1995010519A1 Quinolizinone type compounds |
| 04/20/1995 | WO1995010295A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 04/20/1995 | CA2173856A1 Compounds useful in anti-allergy treatment |
| 04/20/1995 | CA2173459A1 Quinolizinone type compounds |
| 04/19/1995 | EP0648780A1 Heterocyclic thrombin inhibitors |
| 04/19/1995 | EP0648740A1 Amino acid amide derivative, agrohorticultural bactericide, and production process |
| 04/19/1995 | EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 04/19/1995 | EP0648224A1 Conformationally restrained peptide analogs as antiplatelet agents |
| 04/19/1995 | EP0648213A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/19/1995 | EP0455833B1 Amino acid derivative |
| 04/13/1995 | WO1995009868A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 04/13/1995 | WO1995009867A1 Antifungal compositions |
| 04/13/1995 | WO1995009866A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009865A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009864A1 Novel peptide derivative |
| 04/13/1995 | WO1995009859A1 Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring |
| 04/13/1995 | WO1995009858A1 Dipeptide boronic acid inhibitors of trypsin-like enzymes |
| 04/13/1995 | WO1995009843A1 Hiv protease inhibitors |
| 04/13/1995 | WO1995009838A1 INHIBITORS OF β-AMYLOID PROTEIN PRODUCTION |
| 04/13/1995 | WO1995009634A1 Electrophilic peptide analogs as inhibitors of trypsin-like enzymes |
| 04/13/1995 | WO1995009620A1 Sulfoximine and sulfodiimine matrix metalloproteinase inhibitors |
| 04/13/1995 | CA2174311A1 Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring |
| 04/13/1995 | CA2173502A1 Antifungal compositions |
| 04/13/1995 | CA2173460A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 04/12/1995 | EP0647444A1 L-2-oxothiazolidine-4-carboxylate and other stimulators of intracellular glutathione synthesis for reducing or preventing bone marrow hypoplasia |
| 04/12/1995 | EP0647239A1 Angiotensin iv peptides and receptor |
| 04/12/1995 | EP0561827B1 Tetrapeptides deriving from dalbaheptide antibiotics |
| 04/11/1995 | US5405854 Sulfonamidocarboxamides |
| 04/11/1995 | US5405852 Amide derivatives |
| 04/11/1995 | US5405834 Prodrug derivatives of thyrotropin-releasing hormone (TRH) |
| 04/06/1995 | WO1995009149A1 Anthracene derivatives for use as anticancer agent or dye |
| 04/06/1995 | WO1995009001A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995009000A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995008999A1 AMELIORATION OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY DEPOSITION OF AMYLOID β PROTEIN |
| 04/06/1995 | CA2172958A1 Anthracene derivatives for use as anticancer agent or dye |
| 04/06/1995 | CA2172126A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2172125A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2149627A1 Amelioration of amnesia in alzheimer's disease caused by deposition of amyloid .beta. protein |
| 04/06/1995 | CA2133002A1 Method of regulating blood amino acid levels |
| 04/05/1995 | EP0646598A1 New pseudopeptides with antiviral activity containing valine |
| 04/05/1995 | EP0646597A1 New pseudopeptides with antiviral activity containing valine |
| 04/05/1995 | EP0646596A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646595A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646375A1 Method of regulating blood amino acid levels |
| 04/05/1995 | EP0646004A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease |
| 04/05/1995 | EP0593639B1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
| 04/05/1995 | CN1101072A N,N'-(1-OXO-1,2-ethanediyl)-bis-(aspartic acid), salts and use in detergent compositions |
| 04/04/1995 | US5403856 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/04/1995 | US5403581 Administering immunogenic polypeptide to poultry |
| 04/04/1995 | US5403576 Iodo-phenylated chelates for magnetic resonance imaging |
| 04/04/1995 | CA1335083C Fr901228 substance and preparation thereof |
| 04/04/1995 | CA1335075C Method of inhibiting platelet dependent arterial thrombosis |
| 03/30/1995 | WO1995008563A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 03/30/1995 | WO1995008536A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |